Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients.
Phase of Trial: Phase III
Latest Information Update: 24 Apr 2014
At a glance
- Drugs Telmisartan (Primary)
- Indications Diabetes mellitus; Hyperlipidaemia; Hypertension; Metabolic syndrome
- Focus Therapeutic Use
- Acronyms METATEL
- 10 Jun 2017 Biomarkers information updated
- 29 Aug 2011 Results published in the Hypertension.
- 14 Jul 2010 Actual number of patients (56) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History